ClinicalTrials.gg
Not yet recruitingNCT07705802REPSYREUpdated Jul 16, 2026

Outcome of Patients With Severe Mental Illness in the Intensive Care Unit

An observational study in Severe Mental Illness and Severe Mental Disorder, sponsored by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Not yet recruiting at 30 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
18 Years and older
Sex
All
01

Study summary

Severe mental illnesses (SMIs), such as major depression, schizophrenia, and bipolar disorder, carry a significant prevalence among patients admitted to the intensive care unit (ICU), estimated at an average of 19%. Evidence indicates that ICU hospitalization is associated with a poorer prognosis regarding mental health and morbi-mortality compared to hospitalization in conventional wards.

Despite this recognized vulnerability, available data remain limited and are often derived from retrospective studies with conflicting results. Some studies have shown that SMIs impact neither critical care nor long-term mortality. Conversely, other research has reported higher hospital mortality, an increase in complications (such as mechanical ventilation and prolonged length of stay), and unfavorable functional outcomes. Regarding specific conditions like septic shock, unexpected findings have been observed, with certain SMIs appearing to be associated with reduced 90-day mortality compared to a matched control population.

Patients with SMIs thus represent a vulnerable population whose management in the ICU setting may pose specific challenges. This prospective, multicenter study aims to evaluate mortality and identify predictive factors of mortality among patients with SMIs managed in French ICUs.

02

Conditions studied

  • Severe Mental Illness
  • Severe Mental Disorder

Keywords

  • Severe mental illness
  • Intensive care unit
  • Patient outcome
  • Mortality
  • Frailty
  • ICU readmission
  • Severe mental disorder
03

In context

Mental Disorders

1,740 studies on the registry are indexed under Mental Disorders; 348 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 220 across 389 observational studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer is the lead sponsor of 78 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with severe mental illnesses admitted to the ICU for unscheduled medical management, urgent post-operative care, or due to a complication of elective surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years.
  • Admission to a participating ICU.
  • Unscheduled ICU admission for medical management, urgent post-operative care, or due to a complication of elective surgery.
  • Pre-existing diagnosis of a severe mental illness prior to ICU admission, according to criteria: schizophrenia, schizoaffective disorder, severe major depressive episode, chronic depressive disorder, recurrent depressive disorder, or bipolar disorders.
  • Current chronic treatment with psychotropic medication at the time of enrollment (antidepressants, neuroleptics, other antipsychotics, lithium, or antiepileptic drugs used as mood stabilizers).
  • Non-opposition to participate from the patient; if the patient is unable to receive information, non-opposition from a relative/trusted person; for patients under guardianship or curatorship, non-opposition from both the legal guardian and the patient.

Exclusion criteria

Exclusion Criteria:

  • Scheduled ICU admission following elective surgery.
  • Prior enrollment in the REPSYRE study.
  • Inability to speak or understand French.
  • Homeless patients or individuals deprived of liberty.
  • Any other condition or reason that, in the investigator's judgment, might interfere with the evaluation of the study objectives.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with severe mental illness

    Patients with severe mental illnesses (Schizophrenia, schizoaffective disorder, severe major depressive episode, chronic depressive disorder, recurrent depressive disorder, or bipolar disorders) admitted to the intensive care unit for unscheduled medical management, urgent post-operative care, or due to a complication of elective surgery.

    Other: Observational follow-up

Interventions

  • OtherObservational follow-up

    Standard care with a 12-month follow-up period to assess long-term outcomes.

06

What researchers measure

Primary outcomes

  1. All-cause ICU mortality rate

    Assessment of patient vital status (alive or deceased) at the time of intensive care unit (ICU) discharge.

    Time frame: At ICU discharge (up to 1 month)

Secondary outcomes

  1. All-cause mortality rate at specific time points

    Assessment of patient vital status (alive or deceased) for each specified time point.

    Time frame: At ICU discharge (up to 1 month), 3 months, and 12 months post-ICU admission

  2. Time to death

    Evaluation of the exact survival time from ICU admission up to the end of the 12-month follow-up period.

    Time frame: Up to 12 months post-ICU admission

  3. Number of ICU readmissions

    Count of subsequent unscheduled admissions to the ICU for each patient.

    Time frame: 12 months

  4. Glasgow Outcome Scale-Extended (GOSE) score

    Evaluation of global functioning and recovery using the GOSE score. The score ranges from 1 to 8, where higher scores indicate a better functional outcome.

    Time frame: At ICU discharge (up to 1 month), 3 months, and 12 months post-initial ICU admission

  5. Clinical Frailty Scale (CFS) score

    Evaluation of the patient's overall level of fitness and frailty using the CFS. The scale ranges from 1 to 9, where higher scores indicate greater frailty.

    Time frame: At ICU discharge, 3 months, and 12 months post-initial ICU admission

07

Study locations

30 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07705802
Lead sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Responsible party
Sponsor
First posted
Jul 15, 2026
Start date
Sep 2026 (estimated)
Primary completion
Sep 2030 (estimated)
Completion
Sep 2031 (estimated)
Last update
Jul 16, 2026

Study contacts

Magali CESANA, MSc
Contact
magali.cesana@ch-toulon.fr
04 83 77 20 60 ext. +33
Jonathan CHELLY, MD
study director · Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion